Showing posts with label
diseases
.
Show all posts
Showing posts with label
diseases
.
Show all posts
Monday, December 23, 2024
Tempus AI Inc. is a leader in the intersection of AI and precision medicine, offering significant potential for growth in 2025 and beyond
›
Business/Investment Report on Tempus AI Inc. (TEM) - Class A Shares Overview Tempus AI Inc. (Ticker: TEM) is a technology-driven healthcar...
Thursday, July 25, 2024
Adaptive Biotechnologies (ADPT on Nasdaq) is making significant advancements in biotechnology, focusing on harnessing the adaptive immune system for diagnosing and treating diseases
›
One of their primary areas of development is in T-cell receptor (TCR) therapeutics. They have identified and characterized over 8,000 uniq...
Sunday, May 12, 2024
Recursion Pharmaceuticals is at the forefront of AI-driven drug discovery!
›
Recursion Pharmaceuticals has caught the attention of major pharmaceutical companies due to its innovative approach to drug discovery. Mo...
›
Home
View web version
